These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

436 related articles for article (PubMed ID: 24204307)

  • 21. ALS-linked FUS mutants affect the localization of U7 snRNP and replication-dependent histone gene expression in human cells.
    Gadgil A; Walczak A; Stępień A; Mechtersheimer J; Nishimura AL; Shaw CE; Ruepp MD; Raczyńska KD
    Sci Rep; 2021 Jun; 11(1):11868. PubMed ID: 34088960
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of a FUS splicing mutation in a large family with amyotrophic lateral sclerosis.
    Belzil VV; St-Onge J; Daoud H; Desjarlais A; Bouchard JP; Dupré N; Camu W; Dion PA; Rouleau GA
    J Hum Genet; 2011 Mar; 56(3):247-9. PubMed ID: 21160488
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ALS/FTD-Linked Mutation in FUS Suppresses Intra-axonal Protein Synthesis and Drives Disease Without Nuclear Loss-of-Function of FUS.
    López-Erauskin J; Tadokoro T; Baughn MW; Myers B; McAlonis-Downes M; Chillon-Marinas C; Asiaban JN; Artates J; Bui AT; Vetto AP; Lee SK; Le AV; Sun Y; Jambeau M; Boubaker J; Swing D; Qiu J; Hicks GG; Ouyang Z; Fu XD; Tessarollo L; Ling SC; Parone PA; Shaw CE; Marsala M; Lagier-Tourenne C; Cleveland DW; Da Cruz S
    Neuron; 2018 Nov; 100(4):816-830.e7. PubMed ID: 30344044
    [TBL] [Abstract][Full Text] [Related]  

  • 24. FUS contributes to mTOR-dependent inhibition of translation.
    Sévigny M; Bourdeau Julien I; Venkatasubramani JP; Hui JB; Dutchak PA; Sephton CF
    J Biol Chem; 2020 Dec; 295(52):18459-18473. PubMed ID: 33082139
    [TBL] [Abstract][Full Text] [Related]  

  • 25. De novo truncating FUS gene mutation as a cause of sporadic amyotrophic lateral sclerosis.
    DeJesus-Hernandez M; Kocerha J; Finch N; Crook R; Baker M; Desaro P; Johnston A; Rutherford N; Wojtas A; Kennelly K; Wszolek ZK; Graff-Radford N; Boylan K; Rademakers R
    Hum Mutat; 2010 May; 31(5):E1377-89. PubMed ID: 20232451
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Extensive splicing changes in an ALS/FTD transgenic mouse model overexpressing cytoplasmic fused in sarcoma.
    Ito D; Taguchi R; Deguchi M; Ogasawara H; Inoue E
    Sci Rep; 2020 Mar; 10(1):4857. PubMed ID: 32184412
    [TBL] [Abstract][Full Text] [Related]  

  • 27. RNA-binding ability of FUS regulates neurodegeneration, cytoplasmic mislocalization and incorporation into stress granules associated with FUS carrying ALS-linked mutations.
    Daigle JG; Lanson NA; Smith RB; Casci I; Maltare A; Monaghan J; Nichols CD; Kryndushkin D; Shewmaker F; Pandey UB
    Hum Mol Genet; 2013 Mar; 22(6):1193-205. PubMed ID: 23257289
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mice with endogenous TDP-43 mutations exhibit gain of splicing function and characteristics of amyotrophic lateral sclerosis.
    Fratta P; Sivakumar P; Humphrey J; Lo K; Ricketts T; Oliveira H; Brito-Armas JM; Kalmar B; Ule A; Yu Y; Birsa N; Bodo C; Collins T; Conicella AE; Mejia Maza A; Marrero-Gagliardi A; Stewart M; Mianne J; Corrochano S; Emmett W; Codner G; Groves M; Fukumura R; Gondo Y; Lythgoe M; Pauws E; Peskett E; Stanier P; Teboul L; Hallegger M; Calvo A; Chiò A; Isaacs AM; Fawzi NL; Wang E; Housman DE; Baralle F; Greensmith L; Buratti E; Plagnol V; Fisher EM; Acevedo-Arozena A
    EMBO J; 2018 Jun; 37(11):. PubMed ID: 29764981
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sequestration of PRMT1 and Nd1-L mRNA into ALS-linked FUS mutant R521C-positive aggregates contributes to neurite degeneration upon oxidative stress.
    Jun MH; Ryu HH; Jun YW; Liu T; Li Y; Lim CS; Lee YS; Kaang BK; Jang DJ; Lee JA
    Sci Rep; 2017 Jan; 7():40474. PubMed ID: 28094300
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cytoplasmic aggregation of mutant FUS causes multistep RNA splicing perturbations in the course of motor neuron pathology.
    Rezvykh AP; Ustyugov AA; Chaprov KD; Teterina EV; Nebogatikov VO; Spasskaya DS; Evgen'ev MB; Morozov AV; Funikov SY
    Nucleic Acids Res; 2023 Jun; 51(11):5810-5830. PubMed ID: 37115004
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A yeast model of FUS/TLS-dependent cytotoxicity.
    Ju S; Tardiff DF; Han H; Divya K; Zhong Q; Maquat LE; Bosco DA; Hayward LJ; Brown RH; Lindquist S; Ringe D; Petsko GA
    PLoS Biol; 2011 Apr; 9(4):e1001052. PubMed ID: 21541368
    [TBL] [Abstract][Full Text] [Related]  

  • 32. FUS-regulated RNA metabolism and DNA damage repair: Implications for amyotrophic lateral sclerosis and frontotemporal dementia pathogenesis.
    Zhou Y; Liu S; Oztürk A; Hicks GG
    Rare Dis; 2014; 2():e29515. PubMed ID: 25083344
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nuclear localization sequence of FUS and induction of stress granules by ALS mutants.
    Gal J; Zhang J; Kwinter DM; Zhai J; Jia H; Jia J; Zhu H
    Neurobiol Aging; 2011 Dec; 32(12):2323.e27-40. PubMed ID: 20674093
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PARP-1 dependent recruitment of the amyotrophic lateral sclerosis-associated protein FUS/TLS to sites of oxidative DNA damage.
    Rulten SL; Rotheray A; Green RL; Grundy GJ; Moore DA; Gómez-Herreros F; Hafezparast M; Caldecott KW
    Nucleic Acids Res; 2014 Jan; 42(1):307-14. PubMed ID: 24049082
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The
    Yokoi S; Ito T; Sahashi K; Nakatochi M; Nakamura R; Tohnai G; Fujioka Y; Ishigaki S; Udagawa T; Izumi Y; Morita M; Kano O; Oda M; Sone T; Okano H; Atsuta N; Katsuno M; Okada Y; Sobue G
    J Neurosci; 2022 Nov; 42(47):8881-8896. PubMed ID: 36261283
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mutations in the 3' untranslated region of FUS causing FUS overexpression are associated with amyotrophic lateral sclerosis.
    Sabatelli M; Moncada A; Conte A; Lattante S; Marangi G; Luigetti M; Lucchini M; Mirabella M; Romano A; Del Grande A; Bisogni G; Doronzio PN; Rossini PM; Zollino M
    Hum Mol Genet; 2013 Dec; 22(23):4748-55. PubMed ID: 23847048
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Conjoint pathologic cascades mediated by ALS/FTLD-U linked RNA-binding proteins TDP-43 and FUS.
    Ito D; Suzuki N
    Neurology; 2011 Oct; 77(17):1636-43. PubMed ID: 21956718
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Widespread binding of FUS along nascent RNA regulates alternative splicing in the brain.
    Rogelj B; Easton LE; Bogu GK; Stanton LW; Rot G; Curk T; Zupan B; Sugimoto Y; Modic M; Haberman N; Tollervey J; Fujii R; Takumi T; Shaw CE; Ule J
    Sci Rep; 2012; 2():603. PubMed ID: 22934129
    [TBL] [Abstract][Full Text] [Related]  

  • 39. FUS-mediated alternative splicing in the nervous system: consequences for ALS and FTLD.
    Orozco D; Edbauer D
    J Mol Med (Berl); 2013 Dec; 91(12):1343-54. PubMed ID: 23974990
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Frameshift and novel mutations in FUS in familial amyotrophic lateral sclerosis and ALS/dementia.
    Yan J; Deng HX; Siddique N; Fecto F; Chen W; Yang Y; Liu E; Donkervoort S; Zheng JG; Shi Y; Ahmeti KB; Brooks B; Engel WK; Siddique T
    Neurology; 2010 Aug; 75(9):807-14. PubMed ID: 20668259
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.